Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepivacaine for pain relief at insertion of intrauterine contraception (MEPIC)
2020-002271-36Phase 3Completed
- Sponsor
- Danderyds sjukhus
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in pain comparing Mepivacaine intrauterine instillation with Placebo intrauterine instillation (2 arms). Primary endpoint: Pain score at IUC insertion. Started Dec 2020; status: completed.
02
Drugs
mepivacaine
03
Conditions
pain
Beyond the preview
Go deeper on 2020-002271-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002271-36.